Synthetic healthcare data can support interface testing, analytical prototyping, and controlled research experiments. A useful synthetic record resembles the structure needed for a task without being presented as an observation about a real patient. That distinction sounds simple, but it becomes easy to lose when generated rows are exported into familiar clinical tables or used to demonstrate a polished dashboard.
A synthetic healthcare GAN API should therefore be designed around a defined purpose and a release decision, not around an unlimited promise of realistic patient data. This guide proposes a validation workflow for structured records. It does not establish clinical suitability, legal compliance, or anonymity. The synthetic healthcare GAN API overview provides the broader architecture and the boundaries to preserve.
Begin with the smallest useful healthcare task
State exactly what the dataset needs to support. An appointment-screen prototype may require plausible visit categories and dates but no diagnosis history. A research experiment examining relationships among coded conditions needs a different representation and a much more demanding evaluation. Do not import sensitive variables merely because the source database contains them.
Create a purpose statement that names intended users, allowed analyses, excluded uses, and the release environment. Decide whether generated records remain inside a controlled workspace or leave the organization. A dataset suitable for an internal software test may be unsuitable for broad distribution. The access context belongs in the project specification, not only in a final approval email.
Understand what medGAN actually contributes
The medGAN research paper on discrete patient records studies generating multi-label discrete records using an autoencoder and an adversarial network. It is an important example of adapting generative modeling to structured healthcare information rather than assuming an image-oriented architecture transfers unchanged. Its research results are not a certification for another dataset or deployment.
Use that work as a starting point for model selection, then identify the mismatch between the research representation and your own data. A table of coded indicators is not equivalent to longitudinal notes, medical images, medication administration events, or irregular time series. Each representation has different semantics. Calling them all healthcare data does not make their constraints interchangeable.
Build a schema with clinical meaning
Document each field's meaning, type, unit, allowed values, and missing-value convention. Distinguish absent observations from negative findings. A blank laboratory field may mean that a test was not ordered, not that its value was normal. Preserve that distinction in preprocessing and make it visible in the generated dataset's documentation.
Identify logical dependencies that the intended task requires. For example, a discharge timestamp should not precede its admission timestamp under the chosen definition. Unit conversions should be explicit rather than learned accidentally from mixed data. Have a domain reviewer identify constraints that are meaningful for this dataset; do not invent universal clinical rules from a few examples.
Separate identity from useful relationships
Do not train on direct identifiers merely to recreate database-shaped output. Use synthetic identifiers assigned by the pipeline when the application needs keys. Preserve required relationships, such as one synthetic encounter belonging to one synthetic patient, through an explicit relational design. Randomly replacing names while retaining distinctive combinations of sensitive attributes is not a sufficient privacy evaluation.
Split the data before fitting transformations
Choose the split unit to match the task. Where records repeat for one person, placing their encounters across training and evaluation can weaken the independence of the evaluation. Consider patient-level separation and, when relevant, a later time period or different site. Record the rationale rather than treating random row splitting as a default answer.
Fit learned transformations only on the permitted training partition. That includes categorical encoders, imputation strategies, normalization parameters, and model selection. Keep the held-out data separate until the chosen evaluation stage. Write tests that verify which records reached each fitting step. A reproducible split manifest is more reliable than a verbal assurance that the test set was untouched.
Evaluate usefulness without implying clinical efficacy
For an interface test, evaluate schema compatibility, constraint handling, and coverage of required cases. For an analytical prototype, compare relevant distributions and relationships against permitted reference data. Examine subgroups and missingness patterns, not only whole-table averages. The correct evaluation depends on what the synthetic dataset is supposed to enable.
For a downstream prediction experiment, separate the synthetic-data question from the model's clinical value. A model trained on generated records can be evaluated on an appropriate real held-out set, but that exercise alone does not establish readiness for patient care. Record the target, cohort definition, measurement limitations, and intended research context alongside any result.
Avoid publishing a single realism score as a substitute for this work. A dataset might reproduce common patterns while failing to represent rare conditions or unusual care pathways. Show the limitations that matter for the intended use. A useful report tells a reader what not to conclude as clearly as it describes what passed.
Treat privacy as a separate evaluation track
Do not assume that generating new-looking rows removes disclosure risk. Include checks for exact duplication, unusual similarity to source records, and exposure associated with small or distinctive groups. Define the attacker assumptions behind any privacy test. An evaluation that assumes little background knowledge may not describe a recipient who already knows several patient attributes.
Where a formal privacy mechanism is required, ask for its actual definition, parameters, accounting, and implementation review. An ordinary GAN configuration should not be described as differentially private just because it uses random noise. Likewise, passing one membership or similarity test should not be promoted as a universal guarantee. Keep the claim narrower than the evidence.
Protect intermediate artifacts as well as final exports. Training checkpoints, preprocessing files, logs, and cached samples may reveal information or enable additional queries. Assign retention and access rules to each artifact class. A release review that examines only the final CSV misses much of the system's real data handling.
Create a reviewable release package
Return a manifest with schema version, generator revision, sampling configuration, synthetic-record count, validation outcomes, and known exclusions. Include an explicit synthetic designation in the dataset documentation. Keep private training references in controlled records rather than embedding sensitive paths or identifiers in a public export.
Define a human approval step when the release context warrants it. The review should examine intended use, utility findings, privacy evidence, and unresolved limitations together. A technical success in one area should not silently override a failure in another. Store the decision and the approved audience so later reuse does not inherit permissions that were never granted.
Walk through one proposed release
Consider an internal scheduling prototype that needs synthetic patients, encounters, and appointment states. Begin by listing the interface cases the prototype must exercise, including canceled appointments and missing optional fields. Construct synthetic identifiers outside the model and define how every encounter links to its synthetic patient. Do not add sensitive clinical history when the scheduling task does not require it.
Next, run schema and relationship checks, inspect whether required interface cases are represented, and review the privacy implications of the source and generation process. Deliver a manifest that limits the dataset to the approved prototype context. If another team later requests the same files for a predictive clinical experiment, treat that as a new use requiring a new evaluation rather than assuming the original approval carries over.
Conclusion: match the claim to the evidence
The strongest synthetic healthcare workflow is purpose-limited, auditable, and candid about its boundaries. Start with the minimum useful representation, protect the evaluation split, measure task-specific utility, and review disclosure risk separately. Do not turn a successful research experiment into an unsupported promise of clinical safety.
For implementation details beyond healthcare, continue with the synthetic tabular evaluation guide. For the service boundary, read the GAN API architecture guide. Together, these practices help a team build a more inspectable system while keeping decisions about healthcare use with qualified reviewers and the evidence required for that context.
